(MENAFN- AFP) US stocks were mixed in early trade Tuesday, but pharmaceutical companies were boosted as Israel's Teva announced a $40.1 billion cash-and-stock bid for generic drug maker Mylan.
An hour into trade, the Dow Jones Industrial Average was down 43.95 points (0.24 percent) at 17,990.98.
The broad-based S&P 500 slipped 0.34 point (0.02 percent) to 2,100.06.
But the tech-rich Nasdaq Composite held onto gains, adding 18.43 (0.37 percent) at 5,013.03.
Teva's cash-and-stock bid for Mylan would quash Mylan's own offer earlier this month to acquire Perrigo for $28.9 billion.
Mylan shares surged 8.6 percent and Teva gained 2.7 percent, while Perrigo slipped 2.0 percent.
Other drug company shares jumped on the news: Merck added 0.4 percent, Novartis ADRs 2.1 percent, Amgen 1.1 percent and AstraZeneca 1.2 percent.
DuPont shares lost 3.2 percent after it cut its full-year outlook as it raised the expected hit to earnings from currency shifts. The stronger dollar took 25 cents off first-quarter earnings per share, which came in at $1.34, close to expectations.
Iconic motorcycle maker Harley-Davidson cut its prediction for shipments this year, in part due to currency shifts, sending its shares down 9.1 percent.
Bond prices fell. The yield on the 10-year US Treasury rose to 1.91 percent from 1.88 percent Monday, while the 30-year advanced to 2.58 percent from 2.55 percent. Bond prices and yields move inversely.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.